Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Verapamil

Isoptin, Cardinorm e altri

Bibliografia - Quali fonti bibliografiche per Verapamil?

  1. Anderson P. et al., Eur. J. Clin. Pharmacol., 1987, 31(5), 625.

  2. Araie M., Mayama C., Prog. Retin Eye Res., 2011, 30(1), 54.

  3. Bahls F. et al., Neurology, 1991, 41(5), 740.

  4. Bauer L.A. et al., Clin. Pharmacol. Ther., 1992, 52(1), 6.

  5. Barbarash R.A., Drug Intell. Clin. Pharm., 1985, 19(7-8), 559.

  6. Beattie B. et al., Eur. Neurol., 1988, 28(2), 104.

  7. Bleske B.E. et al., Ther. Drug Monit., 1994, 16(2), 216.

  8. Boner A.L. et al., Arch. Dis. Child., 1987, 62, 264.

  9. Brunet L. et al., Drug Saf., 1996, 15(3), 219.

  10. Buckley N. et al., Med. J. Aust., 1993, 158, 202.

  11. Busse D. et al., Naunyn Schmiedebergs Arch. Pharmacol., 1995, 353(1), 116.

  12. Busse D. et al., Eur. J. Clin. Pharmacol., 2006, 62(8), 613.

  13. Campana C. et al., Clin. Pharmacokinet., 1996, 30(2), 141.

  14. Cooper-DeHoff R.M. et al., Expert. Rev. Cardiovasc. Ther., 2009, 7(11), 1329.

  15. Doyon S., Roberts J.R., Ann. Emerg. Med., 1993, 22, 1229.

  16. Echizen H, Eichelbaum M., Clin. Pharmacokkinet., 1986, 11, 425.

  17. Echizen H. et al., J. Cardiovasc. Pharmacol., 1988, 12(5), 543.

  18. Eichelbaum M., Somogyi A., Eur. J. Clin. Pharmacol., 1984, 26, 47.

  19. Foale R.A., Vandenburg M.J., Eur. Heart J., 1992, 13, 256.

  20. Friedensohn A. et al., Cardiology, 1991, 79 Suppl. 2, 31.

  21. Fuhr U. et al., Eur. J. Clin. Pharmacol., 1992, 42(4), 463.

  22. Fuhr U. et al., Drug Saf., 1998, 18(4), 251.

  23. García-Albea E. et al., Clin. Neuropharmacol., 1993, 16(3), 263.

  24. Gibelin P., Presse Med., 2009, 38(6), 1001.

  25. Goldschmidt N. et al., Ann. Pharmacother., 2001, 35(11), 1396.

  26. Gowda R.M. et al., Int. J. Cardiol., 2003, 88(2-3), 129.

  27. Greenberg D.A., Ann. Neurol., 1997, 42(3), 275.

  28. Iannetti P. et al., Epilepsia, 2005, 46(6), 967.

  29. Jaffe R. et al., Ann. Pharmacother., 1994, 28(7-8), 881.

  30. Jenkins L.C., Scoates P.J., Can. Anaesth. Soc. J., 1985, 32(4), 436.

  31. Jürgens T.P. et al., Cephalalgia, 2009, 29(4), 391.

  32. Kaeser Y.A. et al., Am. J. Hearth Syst. Pharm., 1998, 55, 2417.

  33. Kamberi L. et al., Med. Arh., 2010, 64(5), 305.

  34. Klein H.O. et al., Circulation, 1983, 67, 101.

  35. Krecic-Shepard M.E. et al., J. Clin. Pharmacol., 2000, 40(3), 219.

  36. Krecic-shepard M.E. et al., J. Clin. Pharmacol., 2000a, 68(3), 286.

  37. Lanteri-Minet et al., J. Headache Pain., 2011.

  38. Levy N.A., Janicak P.G., Bipolar Disord., 2000, 2(2), 108.

  39. Lim S.H. et al., Resuscitation., 2009, 80(5), 523.

  40. MacPhee G.J. et al., Lancet, 1986, 1, 700.

  41. Mallinger A.G. et al., Bipolar Disord., 2008, 10(8), 856.

  42. Markley H.G., Am. J. Med., 1991, 90(5A), 48S-53S.

  43. Malaterre H.R. et al., Arch. Mal. Coeur. Vaiss., 1992, 85(9), 1335.

  44. McTavish D., Sorkin E.M., Drugs, 1989, 38 (1), 19.

  45. Mikus G. et al., J. Pharmacol. Exp. Ther., 1990, 253(3), 1042.

  46. Miller M.R. et al., Eur. J. Clin. Pharmacol., 1986, 30(1), 125.

  47. Narang P.K. et al., Clin. Pharmacol. Ther., 1988, 44(5), 550.

  48. Nielsen H.K. et al., Int. J. Cardiol., 1989, 23, 357.

  49. Nielsen-Kudsk J.E. et al., Pharmacol. Toxicol., 1990, 66(2), 101.

  50. Orekhov A.N. et al., J. Cardiovasc. Pharmacol., 1988, 12 Suppl. 6, 66.

  51. Orekhov A.N. et al., Drugs, 1992, 44 Suppl. 1, 105.

  52. Orekhov A.N. et al., J. Hum. Hypert., 1991, 5, 425.

  53. Ozkul Y., Clin Neurophysiol., 2007, 118(9), 2005.

  54. Parodi O. et al., Am. J. Cardiol., 1986, 57, 899.

  55. Pepine C.J. et al., JAMA, 2003, 290(21), 2805 (studio INVEST).

  56. Pillai U. et al., South. Med. J., 2009, 102(3), 308.

  57. Pritza D.R. et al., Arch. Intern. Med., 1991, 151(10), 2081.

  58. Przyklenk K., Kloner R.A., J. Am. Coll. Cardiol., 1986,58,541.

  59. Reed M. et al., Ann. Pharmacother., 2005, 39(2), 357.

  60. Rodin S.M. et al., Clin. Pharmacol. Ther., 1988, 43,668.

  61. Rodrigues E.A. et al., Int. J. Cardiol., 1988, 18, 357.

  62. Ruggenenti P. et al., J. Hypertens., 2011, 29(2), 207 (studio BENEDICT-B).

  63. Rumiantsev D.O. et al., Br. J. Clin. Pharmacol., 1989, 28,357.

  64. Rutledge D.R. et al., J. Pharmacol. Exp. Ther., 1988, 246(1), 7.

  65. Solomon G.D., Headache, 1989, 29(7), 425.

  66. Somogyi A. et al., Br. J. Clin. Pharmacol., 1981, 12, 51.

  67. Soward A.L. et al., Br. J. Clin. Pharmacol., 1986, 32, 66.

  68. Spina E. et al., Clin. Pharmacokinet., 1996, 31(3), 198.

  69. Storstein L. et al., Acta Med. Scand. Suppl., 1984, 681, 25.

  70. Summers M.A. et al., Ann. Pharmacother., 2004, 38, 1361.

  71. Takahashi N., Saikawa T., Clin. Calcium., 2005, 15(10), 1651.

  72. Tfelt-Hansen P., Tfelt-Hansen J., Headache., 2009, 49(1), 117.

  73. Théroux P. et al., Drugs, 1983, 25, 178.

  74. Tillmanns H. et al., Eur. Heart J., 1990, 11 Suppl. B., 10.

  75. Toshima H. et al., Jap. Heart J., 1986, 27, 701.

  76. Vogelgesang B. et al., Br. J. Clin. Pharmacol., 1984, 18(5), 733.

  77. Wang Y.H. et al., Drug Metab. Dispos., 2004, 32(2), 259.

  78. Zanchetti A. et al., J. Hypertens., 1998, 16(11), 1667 (studio VHAS).

  79. Zimmermann J.J., AAPS J., 2004, 15, 6(4), e28.